Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Recross Medical is a medical device company specializing in the development and manufacturing of interventional products for complex vascular diseases. The company focuses on providing innovative solutions for Chronic Total Occlusions (CTO) in both coronary and peripheral arteries. Its flagship products include specialized support catheters and dual-lumen catheters designed to improve the success rate of minimally invasive procedures. Headquartered in Suzhou, China, Recross Medical leverages advanced engineering to provide clinicians with better torque control and crossability in calcified lesions. The company has successfully commercialized several products in the Chinese market and is expanding its global footprint. It is backed by prominent venture capital firms including HighLight Capital and Proxima Ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Recross Medical.